Company
Headquarters: Copenhagen, Denmark
Employees: 4
CEO: Dr. Claus Bo Søndergaard Svendsen
$13.8 Million
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$304.61 B |
![]() |
$93.24 B |
![]() |
$79.53 B |
Marinomed Biotech AG | $76.72 B |
![]() |
$74.13 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S has the following listings and related stock indices.
Stock: NASDAQ: FWP
Stock: FSX: 1FPB